Surgery Partners (NASDAQ: SGRY) stock dropped 12% after ending talks with Bain Capital on a potential acquisition. The company remains optimistic about growth, projecting 2025 revenues of $3.30B-$3.45B. An upcoming Investor Day may offer insights for traders.